Elm Street Ventures helps power New Haven biotech
Elm Street Ventures has been instrumental in bringing hundreds of jobs and hundreds of millions in investments to New Haven. “There are a lot of...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Elm Street Ventures has been instrumental in bringing hundreds of jobs and hundreds of millions in investments to New Haven. “There are a lot of...
A team of UConn researchers –- including Assistant Professor of Chemistry in the College of Liberal Arts and Sciences Jessica Rouge and Associate Professor of...
Avera Health and Sema4 have launched a new precision medicine initiative. Avera Cancer Institute has had a robust precision oncology program for several years in...
Bioasis Technologies reports that the Japanese Patent Office has issued Japanese Patent No. 2019-189551 Notice of Allowance for the company’s xB3-IDS fusion proteins. “We are excited...
A special edition of New Haven BIZ spotlights local leaders facing pivotal times. Mentioned in the article are many friends, sponsors, and members of BioCT,...
The U.S. National Science Foundation (NSF) has awarded the University of Connecticut a $40 million research grant award, the largest in the University’s history, to...
Bioasis Technologies reports that it has granted stock options to acquire a total of 1,367,606 common shares effective June 30, 2020. The company also announced the...
Attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations...
New Haven-based biotech Rallybio, founded by three former Alexion executives, pulled in nearly $93 million in its recent IPO. Rallybio is developing drugs for the treatment...
BioCT welcomes Eleanore Seibert, PhD to its Board of Directors. Eleanore is Vice President of Drug Metabolism and Pharmacokinetics within the Research and Development organization at Boehringer...